Hitoshi Kohsaka Selected Research

Hitoshi Kohsaka Research Topics

Disease

26	Rheumatoid Arthritis 12/2023 - 10/2002
18	Myositis (Idiopathic Inflammatory Myopathies) 10/2022 - 04/2007
13	Polymyositis 11/2022 - 08/2009
12	Arthritis (Polyarthritis) 06/2018 - 10/2002
10	Inflammation (Inflammations) 10/2022 - 07/2006
8	Experimental Arthritis 01/2016 - 10/2002
6	Autoimmune Diseases (Autoimmune Disease) 04/2021 - 11/2008
5	Dermatomyositis (Dermatopolymyositis) 11/2022 - 07/2015
4	Fever (Fevers) 12/2023 - 01/2015
4	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2016 - 06/2002
3	Muscle Weakness 10/2022 - 06/2002
3	Churg-Strauss Syndrome (Allergic Angiitis) 04/2019 - 07/2014
3	Infections 04/2019 - 09/2014
3	Aneurysm (Aneurysms) 02/2018 - 01/2016
2	Pancytopenia 12/2023 - 01/2017
2	Vasculitis (Vasculitides) 01/2023 - 01/2016
2	Muscular Diseases (Myopathy) 10/2017 - 11/2013
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2017 - 01/2004
2	Hyperferritinemia 01/2017 - 01/2017
2	Crohn Disease (Crohn's Disease) 01/2016 - 09/2014
2	Multiple Sclerosis 02/2015 - 11/2008
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2023
1	Sepsis (Septicemia) 12/2023
1	Macrophage Activation Syndrome 12/2023
1	Critical Illness (Critically Ill) 12/2023
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Immunoglobulin G4-Related Disease 12/2021
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 04/2021
1	Drug-Related Side Effects and Adverse Reactions 05/2020
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2020
1	Persistent Infection 04/2019
1	Aspergillosis 04/2019
1	Chronic Hepatitis B 04/2019
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2018

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2002
9	AntibodiesIBA 10/2022 - 12/2002
8	tocilizumab (atlizumab)FDA Link 01/2021 - 07/2013
6	Therapeutic UsesIBA 01/2022 - 08/2009
6	Interleukin-6 (Interleukin 6)IBA 01/2016 - 08/2009
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 01/2007
5	GlucocorticoidsIBA 12/2021 - 07/2014
5	AutoantibodiesIBA 11/2018 - 12/2002
5	Prednisolone (Predate)FDA LinkGeneric 01/2017 - 06/2002
5	Collagen Type II (Type II Collagen)IBA 08/2014 - 10/2002
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2008
4	AutoantigensIBA 07/2017 - 11/2008
4	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2012 - 11/2003
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2012 - 09/2005
3	C-Reactive ProteinIBA 01/2023 - 01/2015
3	SteroidsIBA 01/2020 - 11/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2019 - 07/2014
3	Immunoglobulin G (IgG)IBA 02/2018 - 12/2002
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017 - 07/2014
3	Ligases (Synthetase)IBA 01/2016 - 11/2013
3	CytokinesIBA 02/2015 - 10/2010
3	ChemokinesIBA 02/2015 - 03/2013
3	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2012 - 06/2009
2	Leucine (L-Leucine)FDA Link 01/2023 - 05/2015
2	Glycoproteins (Glycoprotein)IBA 01/2023 - 05/2015
2	Branched-Chain Amino AcidsIBA 11/2022 - 11/2013
2	PerforinIBA 10/2022 - 10/2010
2	CollagenIBA 01/2022 - 02/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2021 - 12/2011
2	Antirheumatic Agents (DMARD)IBA 04/2021 - 01/2016
2	Tacrolimus (Prograf)FDA LinkGeneric 04/2019 - 01/2017
2	Immunosuppressive Agents (Immunosuppressants)IBA 04/2019 - 01/2018
2	Abatacept (Orencia)FDA Link 09/2017 - 07/2013
2	Peptides (Polypeptides)IBA 07/2017 - 07/2015
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 07/2017 - 07/2015
2	Infliximab (Remicade)FDA Link 01/2017 - 01/2016
2	EnzymesIBA 01/2017 - 06/2002
2	Etanercept (Enbrel)FDA Link 01/2016 - 08/2014
2	Interleukin-17 (Interleukin 17)IBA 01/2016 - 08/2009
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2016 - 10/2012
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2015 - 08/2012
2	LigandsIBA 09/2014 - 11/2012
2	Messenger RNA (mRNA)IBA 07/2014 - 08/2012
2	Transfer RNA (tRNA)IBA 01/2014 - 03/2009
2	MicroRNAs (MicroRNA)IBA 01/2013 - 01/2012
2	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2012 - 07/2006
1	Cytotoxins (Cytolysins)IBA 12/2023
1	Levofloxacin (Levaquin)FDA Link 12/2023
1	Methotrexate (Mexate)FDA LinkGeneric 12/2023
1	ProcalcitoninIBA 12/2023
1	Granzymes (Granzyme)IBA 10/2022
1	Fas Ligand Protein (Fas Ligand)IBA 10/2022
1	osteoblast cadherinIBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	LY-2157299IBA 01/2022
1	Cyclin-Dependent Kinase 4IBA 01/2022
1	Azathioprine (Imuran)FDA LinkGeneric 12/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 06/2018

Therapy/Procedure

11	Therapeutics 10/2022 - 06/2002
2	Activities of Daily Living (ADL) 01/2018 - 11/2013
1	Contraindications 12/2021
1	Transitional Care 11/2018